These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29366837)

  • 1. The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases.
    Chen Z; He L; Li L; Chen L
    Clin Chim Acta; 2018 Apr; 479():196-207. PubMed ID: 29366837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X7 receptor in cardiovascular disease: The heart side.
    Guerra Martinez C
    Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):513-526. PubMed ID: 30834550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X7 Receptors: An Untapped Target for the Management of Cardiovascular Disease.
    Shokoples BG; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):186-199. PubMed ID: 32998520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2X7 purinergic receptor: A potential target in heart diseases (Review).
    Bin Dayel AF; Alonazi AS; Alshammari TK; Alrasheed NM
    Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36799169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of P2Y2 and P2X7 purinergic receptors in the isolated rat heart mediates ischemia-reperfusion injury.
    Granado M; Amor S; Montoya JJ; Monge L; Fernández N; García-Villalón ÁL
    Vascul Pharmacol; 2015 Oct; 73():96-103. PubMed ID: 26070527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the P2X7 purinergic receptor in inflammation: an update of antagonists series since 2009 and their promising therapeutic potential.
    Baudelet D; Lipka E; Millet R; Ghinet A
    Curr Med Chem; 2015; 22(6):713-29. PubMed ID: 25515510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2X(7) inhibition in stellate ganglia prevents the increased sympathoexcitatory reflex via sensory-sympathetic coupling induced by myocardial ischemic injury.
    Tu G; Li G; Peng H; Hu J; Liu J; Kong F; Liu S; Gao Y; Xu C; Xu X; Qiu S; Fan B; Zhu Q; Yu S; Zheng C; Wu B; Peng L; Song M; Wu Q; Liang S
    Brain Res Bull; 2013 Jul; 96():71-85. PubMed ID: 23688519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2X
    Yin J; Wang Y; Hu H; Li X; Xue M; Cheng W; Wang Y; Li X; Yang N; Shi Y; Yan S
    J Cell Mol Med; 2017 Nov; 21(11):2695-2710. PubMed ID: 28470940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease.
    Bartlett R; Stokes L; Sluyter R
    Pharmacol Rev; 2014 Jul; 66(3):638-75. PubMed ID: 24928329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism.
    Al-Aqtash R; Collier DM
    Channels (Austin); 2024 Dec; 18(1):2355150. PubMed ID: 38762911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of P2X7 receptor on inflammatory diseases and its mechanism].
    Xu H; Liang SD
    Sheng Li Xue Bao; 2013 Apr; 65(2):244-52. PubMed ID: 23598883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-P2X7 Receptor Modulates Axon Initial Segment Composition and Function in Physiological Conditions and Brain Injury.
    Del Puerto A; Fronzaroli-Molinieres L; Perez-Alvarez MJ; Giraud P; Carlier E; Wandosell F; Debanne D; Garrido JJ
    Cereb Cortex; 2015 Aug; 25(8):2282-94. PubMed ID: 24610121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dexamethasone on purinergic signaling in murine mast cells: Selective suppression of P2X7 receptor expression.
    Yoshida K; Ito M; Hoshino Y; Matsuoka I
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1587-1593. PubMed ID: 28988113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2X7 receptor antagonists: a patent review (2010-2015).
    Park JH; Kim YC
    Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2X7 receptor: an emerging target in central nervous system diseases.
    Sperlágh B; Illes P
    Trends Pharmacol Sci; 2014 Oct; 35(10):537-47. PubMed ID: 25223574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probenecid directly impairs activation of the canine P2X7 receptor.
    Bartlett R; Stokes L; Curtis SJ; Curtis BL; Sluyter R
    Nucleosides Nucleotides Nucleic Acids; 2017 Dec; 36(12):736-744. PubMed ID: 29200326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA NONRATT021972 involved the pathophysiologic processes mediated by P2X7 receptors in stellate ganglia after myocardial ischemic injury.
    Zou L; Tu G; Xie W; Wen S; Xie Q; Liu S; Li G; Gao Y; Xu H; Wang S; Xue Y; Wu B; Lv Q; Ying M; Zhang X; Liang S
    Purinergic Signal; 2016 Mar; 12(1):127-37. PubMed ID: 26630943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhein antagonizes P2X7 receptor in rat peritoneal macrophages.
    Hu F; Xing F; Zhu G; Xu G; Li C; Qu J; Lee I; Pan L
    Sci Rep; 2015 Sep; 5():14012. PubMed ID: 26354875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of P2X7 receptor in PC12 cells after exposure to oxygen-glucose deprivation.
    Fan B; Liu S; Xu C; Liu J; Kong F; Li G; Zhang C; Gao Y; Xu H; Yu S; Zheng C; Peng L; Song M; Wu B; Lv Q; Zou L; Ying M; Zhang X; Liang S
    Auton Neurosci; 2014 Oct; 185():36-42. PubMed ID: 24746144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2X7 receptor antagonist activity of the anti-allergic agent oxatomide.
    Yoshida K; Ito M; Matsuoka I
    Eur J Pharmacol; 2015 Nov; 767():41-51. PubMed ID: 26463039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.